Literature DB >> 22964045

Rotavirus in diarrheal children in rural Burkina Faso: high prevalence of genotype G6P[6].

Johan Nordgren1, Isidore Juste O Bonkoungou, Leon W Nitiema, Sumit Sharma, Djeneba Ouermi, Jacques Simpore, Nicolas Barro, Lennart Svensson.   

Abstract

Group A rotavirus (RVA) is the most common cause of severe gastroenteritis in young children globally, and responsible for a significant number of deaths in African countries. While vaccines are available, trials have shown a lesser efficacy in Africa. One of the reasons could be the prevalence and/or emergence of unusual or novel RVA strains, as many strains detected in African countries remain uncharacterized. In this study, we characterized RVA positive specimens from two remote rural areas in Burkina Faso, West Africa. In total 56 RVA positive specimens were subgrouped by their VP6 gene, and G-and P typed by PCR and/or sequencing of the VP7 and VP4 genes, respectively. Notably, we found a high prevalence of the unusual G6P[6]SGI strains (23%). It was the second most common constellation after G9P[8]SGII (32%); and followed by G1P[8]SGII (20%) and G2P[4]SGI (9%). We also detected a G8P[6]SGI strain, for the first time in Burkina Faso. The intra-genetic diversity was high for the VP4 gene with two subclusters within the P[8] genotype and three subclusters within the P[6] genotype which were each associated with a specific G-type, thereby suggesting a genetic linkage. The G6P[6]SGI and other SGI RVA strains infected younger children as compared to SGII strains (p<0.05). To conclude, in this study we observed the emergence of unusual RVA strains and high genetic diversity of RVA in remote rural areas of Burkina Faso. The results highlight the complexity of RVA epidemiology which may have implication for the introduction of rotavirus vaccines currently being evaluated in many African countries.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22964045     DOI: 10.1016/j.meegid.2012.08.014

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  12 in total

1.  Norovirus and rotavirus survival in urine collected from a public ecological sanitation system in Ouagadougou, Burkina Faso.

Authors:  Joseph M Makaya; Jérôme Kaplon; Céline Fremy; Nicolas Barro; Serge Aho; Pierre Pothier; Gaël Belliot; Alfred S Traoré
Journal:  Food Environ Virol       Date:  2014-11-19       Impact factor: 2.778

Review 2.  Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure?

Authors:  Renáta Dóró; Brigitta László; Vito Martella; Eyal Leshem; Jon Gentsch; Umesh Parashar; Krisztián Bányai
Journal:  Infect Genet Evol       Date:  2014-09-16       Impact factor: 3.342

3.  Whole-genome sequencing and analyses identify high genetic heterogeneity, diversity and endemicity of rotavirus genotype P[6] strains circulating in Africa.

Authors:  Martin M Nyaga; Yi Tan; Mapaseka L Seheri; Rebecca A Halpin; Asmik Akopov; Karla M Stucker; Nadia B Fedorova; Susmita Shrivastava; A Duncan Steele; Jason M Mwenda; Brett E Pickett; Suman R Das; M Jeffrey Mphahlele
Journal:  Infect Genet Evol       Date:  2018-05-18       Impact factor: 3.342

4.  Impact and effectiveness of pentavalent rotavirus vaccine in children <5 years of age in Burkina Faso.

Authors:  Isidore Juste O Bonkoungou; Negar Aliabadi; Eyal Leshem; Madibèlè Kam; Désiré Nezien; Maxime K Drabo; Moumouni Nikiema; Boureima Ouedraogo; Isaïe Medah; Souleymane Konaté; Rasmata Ouédraogo-Traoré; Lassana Sangaré; Ludovic Kam; Diarra Yé; Ma Ouattara; Joseph N Biey; Jason M Mwenda; Jacqueline E Tate; Umesh D Parashar
Journal:  Vaccine       Date:  2017-12-28       Impact factor: 4.169

Review 5.  Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy.

Authors:  Xi Jiang; Yang Liu; Ming Tan
Journal:  Emerg Microbes Infect       Date:  2017-04-12       Impact factor: 7.163

6.  Characterization of rotavirus infection in children with acute gastroenteritis in Bengo province, Northwestern Angola, prior to vaccine introduction.

Authors:  Carolina Gasparinho; João Piedade; Maria Clara Mirante; Cristina Mendes; Carlos Mayer; Susana Vaz Nery; Miguel Brito; Claudia Istrate
Journal:  PLoS One       Date:  2017-04-19       Impact factor: 3.240

7.  Rotavirus A in Brazil: Molecular Epidemiology and Surveillance during 2018-2019.

Authors:  Meylin Bautista Gutierrez; Alexandre Madi Fialho; Adriana Gonçalves Maranhão; Fábio Correia Malta; Juliana da Silva Ribeiro de Andrade; Rosane Maria Santos de Assis; Sérgio da Silva E Mouta; Marize Pereira Miagostovich; José Paulo Gagliardi Leite; Tulio Machado Fumian
Journal:  Pathogens       Date:  2020-06-27

8.  Molecular surveillance of rotavirus strains circulating in Yaoundé, Cameroon, September 2007-December 2012.

Authors:  Angeline Boula; Diane Waku-Kouomou; Mina Njiki Kinkela; Mathew D Esona; Grace Kemajou; David Mekontso; Mapaseka Seheri; Valantine Ngum Ndze; Irene Emah; Serge Ela; Benjamin A Dahl; Marie Kobela; Kathleen F Cavallaro; Georges Alain Etoundi Mballa; Jon R Genstch; Michael D Bowen; Paul Koki Ndombo
Journal:  Infect Genet Evol       Date:  2014-09-16       Impact factor: 4.393

9.  Rotavirus surveillance in Kisangani, the Democratic Republic of the Congo, reveals a high number of unusual genotypes and gene segments of animal origin in non-vaccinated symptomatic children.

Authors:  Elisabeth Heylen; Bibi Batoko Likele; Mark Zeller; Stijn Stevens; Sarah De Coster; Nádia Conceição-Neto; Christel Van Geet; Jan Jacobs; Dauly Ngbonda; Marc Van Ranst; Jelle Matthijnssens
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

10.  A Multiplex PCR/LDR Assay for Viral Agents of Diarrhea with the Capacity to Genotype Rotavirus.

Authors:  Aashiq H Mirza; Sanchita Das; Maneesh R Pingle; Mark S Rundell; George Armah; Ben Gyan; Richard L Hodinka; Davise H Larone; Eric D Spitzer; Francis Barany; Linnie M Golightly
Journal:  Sci Rep       Date:  2018-09-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.